Examkin

Soru

Zorluk: ZorPreventive Care and Immunizations

A 2-month-old boy is brought to the clinic for a routine well-child visit. He was diagnosed with 22q11.2 deletion syndrome shortly after birth following an evaluation for a cardiac murmur and tetany. Echocardiography at that time revealed a tetralogy of Fallot, which is awaiting surgical repair. Recent immunologic evaluation demonstrated a markedly reduced CD3+ T-lymphocyte count of 200/mm³. Today, the infant is feeding well and gaining weight appropriately. During the examination, he demonstrates a social smile, vocalizes with cooing sounds, and tracks a colorful toy past the midline. He does not yet roll over or reach for objects. The mother expresses concern that his development may be delayed. His immunization records show he received the hepatitis B vaccine at birth and 1 month of age. Which of the following is the most appropriate management for this patient today?

  1. Reassure the mother regarding his development; administer DTaP, Hib, IPV, and PCV vaccines; and defer the rotavirus vaccineCevap
  2. B
    Reassure the mother regarding his development and administer DTaP, Hib, IPV, PCV, and rotavirus vaccines
  3. C
    Refer the infant for early developmental intervention; administer DTaP, Hib, IPV, and PCV vaccines; and defer the rotavirus vaccine
  4. D
    Refer the infant for early developmental intervention and administer DTaP, Hib, IPV, PCV, and rotavirus vaccines
  5. E
    Reassure the mother regarding his development and defer all immunizations until the T-lymphocyte count normalizes

Cevap

Reassure the mother regarding his development; administer DTaP, Hib, IPV, and PCV vaccines; and defer the rotavirus vaccine.
The correct answer addresses both the patient's normal development and the necessary modifications to his immunization schedule. A 2-month-old infant is expected to demonstrate a social smile, coo, and track objects past the midline. The inability to roll over or reach for objects is normal at this age (these are typically achieved by 4 months). Therefore, the mother should be reassured. Regarding immunizations, this patient has 22q11.2 deletion syndrome (DiGeorge syndrome) with confirmed severe T-lymphocyte deficiency. Live-attenuated vaccines, such as the oral rotavirus vaccine, are absolutely contraindicated in patients with severe cell-mediated immunodeficiencies due to the risk of uncontrolled vaccine-strain infection. However, inactivated, toxoid, and subunit vaccines (DTaP, Hib, IPV, PCV) are safe and should be administered according to the routine schedule to provide necessary protection.

Adım Adım Çözüm

1
Evaluate the infant's developmental milestones based on his chronological age of 2 months.
The infant exhibits a social smile, cooing, and tracking past the midline, which are normal 2-month milestones. Rolling over and reaching for objects are typically achieved at 4 months.
Accurate milestone assessment prevents unnecessary anxiety and improper referrals for early intervention.
2
Identify the implications of the patient's underlying genetic diagnosis.
22q11.2 deletion syndrome (DiGeorge syndrome) is associated with thymic hypoplasia, leading to severe T-lymphocyte deficiency, confirmed here by a low CD3+ count.
Understanding the patient's immune status is critical for safely prescribing immunizations.
3
Determine the contraindications for the standard 2-month immunization bundle.
The standard 2-month bundle includes DTaP, Hib, IPV, PCV, and rotavirus. Rotavirus is a live-attenuated vaccine and is absolutely contraindicated in severe cell-mediated immunodeficiencies.
Live-attenuated vaccines can cause severe, disseminated disease in patients with profound T-cell defects.
4
Formulate the final management plan.
Reassure the mother that development is normal, safely administer the inactivated vaccines (DTaP, Hib, IPV, PCV), and withhold the rotavirus vaccine.
Inactivated vaccines are safe and essential for protecting immunocompromised patients from invasive bacterial and viral infections.

Anahtar Kavram

Live-attenuated vaccines (e.g., rotavirus) are contraindicated in patients with severe cell-mediated immunodeficiencies (e.g., severe DiGeorge syndrome), whereas inactivated vaccines should be administered on schedule. Normal 2-month milestones include social smiling, cooing, and tracking past the midline.
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru